Cite
APA Citation
Pelz, A., Schaffert, H., Diallo, R., Hiepe, F., Meisel, A., & Kohler, S. (2018). s1P receptor antagonists fingolimod and siponimod do not improve the outcome of experimental autoimmune myasthenia gravis mice after disease onset. European journal of immunology, 48(3), 498–508. http://access.bl.uk/ark:/81055/vdc_100057596301.0x000040